Trial Profile
A Phase II Study of Dexamethasone (DECADRON), Clarithromycin (BIAXIN), and Pomalidomide (CC-4047) for Subjects With Relapsed or Refractory Multiple Myeloma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2019
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Clarithromycin; Dexamethasone
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- 28 May 2019 Status changed from active, no longer recruiting to completed.
- 13 Feb 2017 Planned number of patients changed from 54 to 121.
- 13 Feb 2017 Planned End Date changed from 1 Jun 2013 to 1 Jun 2020.